Discover the full record of transactions filed by Curran Terrie, Chairman & CEO. Insider active across 3 companies, notably Myovant Sciences Ltd.. Aggregated, 9 filings have been recorded. Total volume traded: €146k. The latest transaction was filed on 1 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Terrie Curran is President and Chief Executive Officer at Myovant Sciences Ltd., Phathom Pharmaceuticals, Inc., and Arcutis Biotherapeutics, Inc. She leads these companies with a focus on innovation and growth. Her leadership is essential for the development of new treatments.